Literature DB >> 27176213

Silencing Transient Receptor Potential Vanilloid Receptor Subtype I-containing Sensory Neurons to Treat Bone Cancer Pain.

Christopher M Peters1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27176213      PMCID： PMC5257273          DOI： 10.1097/ALN.0000000000001153

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  11 in total

1.  The quaternary lidocaine derivative, QX-314, produces long-lasting local anesthesia in animal models in vivo.

Authors:  Tony K Y Lim; Bernard A Macleod; Craig R Ries; Stephan K W Schwarz
Journal:  Anesthesiology       Date:  2007-08       Impact factor: 7.892

2.  Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade.

Authors:  Zhen-Zhong Xu; Yong Ho Kim; Sangsu Bang; Yi Zhang; Temugin Berta; Fan Wang; Seog Bae Oh; Ru-Rong Ji
Journal:  Nat Med       Date:  2015-10-19       Impact factor: 53.440

3.  A comparison of the systemic toxicity of lidocaine versus its quaternary derivative QX-314 in mice.

Authors:  Helen M C Cheung; Sang Mook Lee; Bernard A MacLeod; Craig R Ries; Stephan K W Schwarz
Journal:  Can J Anaesth       Date:  2011-03-03       Impact factor: 5.063

4.  Lumbar intrathecal administration of the quaternary lidocaine derivative, QX-314, produces irritation and death in mice.

Authors:  Stephan K W Schwarz; Helen M-C Cheung; Craig R Ries; Sang Mook Lee; Jimmy T C Wang; Bernard A MacLeod
Journal:  Anesthesiology       Date:  2010-08       Impact factor: 7.892

5.  Systemic QX-314 Reduces Bone Cancer Pain through Selective Inhibition of Transient Receptor Potential Vanilloid Subfamily 1-expressing Primary Afferents in Mice.

Authors:  Satoshi Fuseya; Katsumi Yamamoto; Hitoshi Minemura; Satoshi Yamaori; Tomoyuki Kawamata; Mikito Kawamata
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

6.  Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain.

Authors:  Joseph R Ghilardi; Heidi Röhrich; Theodore H Lindsay; Molly A Sevcik; Matthew J Schwei; Kazufumi Kubota; Kyle G Halvorson; Jeannie Poblete; Sandra R Chaplan; Adrienne E Dubin; Nicholas I Carruthers; Devin Swanson; Michael Kuskowski; Christopher M Flores; David Julius; Patrick W Mantyh
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

7.  Fast-conducting mechanoreceptors contribute to withdrawal behavior in normal and nerve injured rats.

Authors:  Danilo M Boada; Thomas J Martin; Christopher M Peters; Kenichiro Hayashida; Michael H Harris; Timothy T Houle; Edward S Boyden; James C Eisenach; Douglas G Ririe
Journal:  Pain       Date:  2014-09-28       Impact factor: 7.926

8.  Nociceptor-selective peripheral nerve block induces delayed mechanical hypersensitivity and neurotoxicity in rats.

Authors:  Christopher M Peters; Douglas Ririe; Timothy T Houle; Carol A Aschenbrenner; James C Eisenach
Journal:  Anesthesiology       Date:  2014-04       Impact factor: 7.892

9.  A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: therapeutic opportunity for treating skeletal pain.

Authors:  Juan Miguel Jimenez-Andrade; William G Mantyh; Aaron P Bloom; Haili Xu; Alice S Ferng; Gregory Dussor; Todd W Vanderah; Patrick W Mantyh
Journal:  Bone       Date:  2009-09-18       Impact factor: 4.398

10.  SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain.

Authors:  Y Niiyama; T Kawamata; J Yamamoto; S Furuse; A Namiki
Journal:  Br J Anaesth       Date:  2008-11-26       Impact factor: 9.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.